Amgen

Amgen falls on analyst rating; indexes slip
Marketwatch
Mon, 08/16/10 - 11:49 am
Amgen
analysts
Amgen: Vectibix fails in head and neck cancer test
Yahoo/AP
Wed, 08/11/10 - 11:31 am
head and neck cancer
Amgen
Vectibix
Are Amgen Sales Reps Looking At Your Medical Records?
BNET Pharma
Mon, 08/9/10 - 02:15 pm
Amgen
medical records
lawsuits
drug reps
Affymax Lives to Fight Another Day
Motley Fool
Mon, 08/9/10 - 11:06 am
Affymax
anemia
Takeda
Amgen
Former Amgen Reps Say Arbitration Hides Misdeeds
Pharmalot
Thu, 08/5/10 - 11:28 am
Amgen
arbitration
off-label
fraud
HIPPA
3 Big Bets on Health Care
Yahoo/Motley Fool
Thu, 08/5/10 - 09:23 am
Abbott Laboratories
Immunogen
Amgen
Big Pharma Won't Wait in Rush for Biotech's Drugs
WSJ Online
Wed, 08/4/10 - 11:30 am
Bristol-Myers Squibb
ZymoGenetics
Amgen
Big Pharma
Abbott Laboratories
Array Biopharma
Amgen: On the Path to a Blockbuster
Motley Fool
Fri, 07/30/10 - 11:23 am
Prolia
Amgen
osteoporosis
Amgen Q2 Beats, Driven by International Sales
Barron's
Fri, 07/30/10 - 12:25 am
Amgen
earnings
Earnings Preview: Amgen to report 2nd-qtr results
Yahoo/AP
Wed, 07/28/10 - 11:19 am
Amgen
earnings
Big Biotech: End of an Era
Seeking Alpha
Wed, 07/28/10 - 10:17 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Genentech
Dendreon
Genzyme
Gilead Sciences
GSK
Roche
Human Genome Sciences
Vertex Pharmaceuticals
Sanofi
Analyst: New CMS rule on payment system may boost shares of Amgen, Genzyme
Yahoo/AP
Tue, 07/27/10 - 10:37 am
CMS
Amgen
Genzyme
Medicare
Medicaid
Amgen gets rapid FDA review for denosumab
Yahoo/AP
Mon, 07/19/10 - 09:30 am
Amgen
FDA
Prolia
denosumab
Amgen drug gets priority review for bone cancer
Marketwatch
Sun, 07/18/10 - 07:46 am
bone cancer
Amgen
FDA
denosumab
Prolia
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
Yahoo/PR NewsWire
Sat, 07/17/10 - 09:52 am
Amgen
denosumab
skeletal metastases
Affymax Sell-Off: Did Investors Overreact?
Seeking Alpha
Thu, 07/8/10 - 09:27 am
Affymax
Amgen
Takeda
EPO
Epogen
Micera
Roche
investors
The Best Biotech Takeover Targets
Seeking Alpha
Mon, 07/5/10 - 10:27 am
biotech
Allergan
Amgen
M&A
Celgene
Biogen Idec
Genzyme
Gilead Sciences
Sanofi
June's Biotech Busts And Breakthroughs
Forbes
Sat, 07/3/10 - 10:00 am
biotech
companies
Celgene
Neurocrine
Abbott Laboratories
Dendreon
Exelixis
Affymax
Amgen
What Ails Amgen?
Investopedia
Thu, 07/1/10 - 08:43 am
Amgen
M&A
Aranesp
anemia
oncology
Biotech Stocks Losing Strength
Minyanville
Wed, 06/23/10 - 10:56 am
biotech
Amgen
Gilead Sciences
Biogen Idec
Merck
Eli Lilly
Pfizer
GSK

Pages